Standard BioTools Operating Expenses 2010-2024 | LAB
Standard BioTools operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
| Standard BioTools Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2023 | $183 |
| 2022 | $214 |
| 2021 | $198 |
| 2020 | $189 |
| 2019 | $169 |
| 2018 | $161 |
| 2017 | $160 |
| 2016 | $178 |
| 2015 | $165 |
| 2014 | $168 |
| 2013 | $90 |
| 2012 | $70 |
| 2011 | $61 |
| 2010 | $48 |
| 2009 | $43 |
| Standard BioTools Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2024-09-30 | $77 |
| 2024-06-30 | $88 |
| 2024-03-31 | $106 |
| 2023-12-31 | $50 |
| 2023-09-30 | $47 |
| 2023-06-30 | $45 |
| 2023-03-31 | $42 |
| 2022-12-31 | $48 |
| 2022-09-30 | $55 |
| 2022-06-30 | $57 |
| 2022-03-31 | $54 |
| 2021-12-31 | $50 |
| 2021-09-30 | $48 |
| 2021-06-30 | $48 |
| 2021-03-31 | $52 |
| 2020-12-31 | $62 |
| 2020-09-30 | $45 |
| 2020-06-30 | $40 |
| 2020-03-31 | $43 |
| 2019-12-31 | $42 |
| 2019-09-30 | $40 |
| 2019-06-30 | $43 |
| 2019-03-31 | $44 |
| 2018-12-31 | $43 |
| 2018-09-30 | $41 |
| 2018-06-30 | $39 |
| 2018-03-31 | $38 |
| 2017-12-31 | $36 |
| 2017-09-30 | $40 |
| 2017-06-30 | $40 |
| 2017-03-31 | $43 |
| 2016-12-31 | $43 |
| 2016-09-30 | $41 |
| 2016-06-30 | $46 |
| 2016-03-31 | $48 |
| 2015-12-31 | $44 |
| 2015-09-30 | $36 |
| 2015-06-30 | $43 |
| 2015-03-31 | $41 |
| 2014-12-31 | $43 |
| 2014-09-30 | $43 |
| 2014-06-30 | $40 |
| 2014-03-31 | $42 |
| 2013-12-31 | $26 |
| 2013-09-30 | $23 |
| 2013-06-30 | $21 |
| 2013-03-31 | $20 |
| 2012-12-31 | $19 |
| 2012-09-30 | $17 |
| 2012-06-30 | $17 |
| 2012-03-31 | $17 |
| 2011-12-31 | $16 |
| 2011-09-30 | $15 |
| 2011-06-30 | $17 |
| 2011-03-31 | $14 |
| 2010-12-31 | $12 |
| 2010-09-30 | $12 |
| 2010-06-30 | $12 |
| 2010-03-31 | $12 |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.800B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.384B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.892B | 183.76 |
| Hims & Hers Health (HIMS) | United States | $5.028B | 130.06 |
| Axonics (AXNX) | United States | $3.600B | 1760.50 |
| IRhythm Technologies (IRTC) | United States | $2.707B | 0.00 |
| Enovis (ENOV) | United States | $2.594B | 17.58 |
| Privia Health (PRVA) | United States | $2.547B | 213.00 |
| Omnicell (OMCL) | United States | $2.306B | 75.97 |
| Azenta (AZTA) | United States | $2.190B | 124.39 |
| 10x Genomics (TXG) | United States | $1.893B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.696B | 0.00 |
| Schrodinger (SDGR) | United States | $1.365B | 0.00 |
| Phreesia (PHR) | United States | $1.228B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.589B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.558B | 0.00 |
| Talkspace (TALK) | United States | $0.555B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.500B | 84.80 |
| Health Catalyst (HCAT) | United States | $0.498B | 0.00 |
| Pulmonx (LUNG) | United States | $0.294B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.230B | 0.00 |
| TruBridge (TBRG) | United States | $0.203B | 58.91 |
| American Well (AMWL) | United States | $0.135B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.108B | 0.00 |
| HeartBeam (BEAT) | United States | $0.068B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.045B | 0.00 |
| CareCloud (CCLD) | United States | $0.044B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Movano (MOVE) | United States | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |